Last updated 2026-08-24
- Raised $10M debt round led by European Investment Bank, Jan 2025
- Raised $21.6M Series B led by Asabys Partners, Dec 2019
- Raised $16.2M Series A led by Omega Funds, May 2017
Total raised
$50.6M
Stage
—
Founded
2015
Headcount
—
HQ
Sant Quirze del Vallès, Barcelona, Spain
Sector
Healthcare & Life Sciences
About
Anaconda Biomed S.L. is a Spanish medical device company focused on revolutionizing stroke treatment. The company develops next-generation thrombectomy systems, including the ANA Funnel Catheter, designed to enhance outcomes in ischemic stroke treatment through precision engineering and cutting-edge technology. The ANA Funnel Catheter is designed to envelop clots effectively, similar to the anaconda snake's ability to consume larger prey, and aims to improve clot retrieval procedures by combining aspiration with flow restriction.
Funding history · 6 rounds · $50.6M total
2025-01
Debt Financing
$10.0M
★ European Investment Bank
2019-12
B Round
$21.6M
★ Asabys PartnersInnogestOmega FundsYsios CapitalSabadell Venture Capital
2018-08
Grant
Undisclosed
★ EIT Health
2017-05
A Round
$16.2M
★ Omega Funds★ Ysios Capital★ Banco Sabadell★ Innogest Capital
2017-05
A Round
$15.0M
★ Omega Funds★ Ysios Capital★ Banco Sabadell★ Innogest Capital
2016-05
Seed
Undisclosed
★ Uri Fligil★ Ariel Katz★ Giovanni Leo★ Claudio Rumazza
Q&A
- What is Anaconda BioMed's primary focus?
- Anaconda BioMed is a Spanish medical device company focused on developing next-generation thrombectomy systems for stroke treatment, including the ANA Funnel Catheter.
- When was Anaconda BioMed founded?
- Anaconda BioMed was founded in 2015.
- Who are the co-founders of Anaconda BioMed?
- The co-founders of Anaconda BioMed are Marc Ribo and Ofir Arad.
- Who is the current CEO of Anaconda BioMed?
- Trent Reutiman was appointed CEO of Anaconda BioMed in January 2025.
- Who is the current Board Chairman of Anaconda BioMed?
- Chuck Carignan was appointed Board Chairman of Anaconda BioMed in June 2025.
- When did Anaconda BioMed secure its Series A funding?
- Anaconda BioMed secured $15,000,000 in Series A funding in May 2017, led by Omega Funds.
- Which investors participated in Anaconda BioMed's Series B funding round?
- Anaconda BioMed secured $21,600,000 in Series B funding in December 2019, led by Asabys Partners.
- What is the total amount of funding raised by Anaconda BioMed?
- Anaconda BioMed has raised a total of $36,600,000 in funding.
Team · 14
Dr. Ofir Arad
Founder · Co-Founder and Managing Director
Dr. Marc Ribó
Founder · Co-Founder
Trent Reutiman
CEO
Hendrik Lambert
CMO
Dr. Iñaki Galve
R&D Director
Maria Jose Alonso
Finance Director
Jordi Cardona
Operations Director
Monica Barrett
RA/QA Director
Tina Cordaro
VP, Clinical Affairs
Chuck Carignan, MD
Board Chairman
Thomas Harth
Board Member (YSIOS CAPITAL)
Claudio Nessi
Board Member (OMEGAFUNDS-NeoMed)
Sylvain Sachot
Board Member
Marco Venturelli
Board Member (Origine SGR SpA)
Sectors & technology
Primary sector
Healthcare & Life Sciences
Technologies
Target customers
Business model
B2BHardware Sales
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | anaconda.bio |
|---|
Identifiers & details
| Legal name | Anaconda Biomed S.L. |
|---|---|
| Founded | 2015 |
Radar intelligence
Patents
| EPO | 20 |
|---|
Web history (Wayback)
| Domain | anaconda.bio |
|---|